• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Manifest Learning Academy
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Science & Tech

Bio E’s corbevax vaccine

June 7, 2021
in Science & Tech
Reading Time: 4 mins read
0
Bio E’s corbevax vaccine
152
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook
image_pdfMake PDF

In news 

Corbevax would be India’s cheapest vaccine at Rs 250 per dose once it gets emergency use approva

Key updates 

  • Corbevax is undergoing phase III trials and with phase I & II trials showing promising results, the Centre has pre-booked 30 crore doses for an advance payment of Rs 1,500 crore.
  • It is being developed by Hyderabad-based company Biological E.
  • This is the first time the Indian government has placed an order for a vaccine that has not received emergency use authorization. 
  • The Centre has provided major pre-clinical and clinical trial support towards the vaccine’s development, including a grant-in-aid of Rs 100 crore from the Department of Biotechnology.

How does Corbevax work? 

  • Corbevax is a “recombinant protein sub-unit” vaccine, which means it is made up of a specific part of SARS-CoV-2 the spike protein on the virus’s surface.
  • The spike protein allows the virus to enter the cells in the body so that it can replicate and cause disease. However, when this protein alone is given to the body, it is not expected to be harmful as the rest of the virus is absent. 
  • The body is expected to develop an immune response against the injected spike protein. 
  • Therefore, when the real virus attempts to infect the body, it will already have an immune response ready that will make it unlikely for the person to fall severely ill.
  • Although this technology has been used for decades to make hepatitis B vaccines, Corbevax will be among the first Covid-19 vaccines to use this platform. 

How was Corbevax made?

  • While it is indigenously produced, Corbevax’s beginnings can be traced to the Baylor College of Medicine’s National School of Tropical Medicine. The School had been working on recombinant protein vaccines for coronaviruses SARS and MERS for a decade.
  • When the genetic sequence for SARS-CoV-2 was made available in February 2020, researchers at the School pulled out the sequence for the gene for the spike protein, and worked on cloning and engineering it. 
  • The gene was then put into yeast, so that it could manufacture and release copies of the protein.
  • After this, the protein was purified to remove any remnants of the yeast “to make it pristine”.
  • Then, the vaccine was formulated using an adjuvant to better stimulate the immune response.
  • Recently, BCM transferred its production cell bank for this vaccine to Biological E, so that the Hyderabad-based company could take the candidate through trials. 

Difference between Corbevax and other vaccines

Other Covid-19 vaccines approved so far are either mRNA vaccines (Pfizer and Moderna), viral vector vaccines (AstraZeneca-Oxford/Covishield, Johnson & Johnson and Sputnik V) or inactivated vaccines (Covaxin, Sinovac-CoronaVac and Sinopharm’s SARS-CoV-2 Vaccine–Vero Cell).

mRNA(messenger ribonucleic acid )

Messenger RNA (mRNA) is a single-stranded RNA molecule that is complementary to one of the DNA strands of a gene.  The mRNA is an RNA version of the gene that leaves the cell nucleus and moves to the cytoplasm where proteins are made.

  • Inactivated vaccines, which include killed particles of the whole SARS-CoV-2 virus, attempt to target the entire structure of the virus. 
  • On the other hand, Corbevax, like the mRNA and viral vector Covid-19 vaccines, targets only the spike protein, but in a different way.
  • Viral vector and mRNA and vaccines use a code to induce our cells to make the spike proteins against which the body has to build immunity. 
  • In this case (Corbevax), researchers are actually giving the protein.
  • Like most other Covid-19 vaccines, Corbevax is administered in two doses. However, as it is made using a low-cost platform, it is also expected to be among the cheapest available in the country.

About Biological E,  

  • Biological E, headquartered in Hyderabad, was founded by Dr D V K Raju in 1953 as a biological products company that pioneered the production of heparin in India. 
  • By 1962, it forayed into the vaccines space, producing DPT vaccines on a large-scale. 
  • Today, it is among the major vaccine makers in India and, by its own claim, the “largest” tetanus vaccine producer in the world.
  • It has seven WHO-prequalified shots, including a five-in-one vaccine against diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza type-b infections. 
  • Its vaccines are supplied to over 100 countries and it has supplied more than two billion doses in the last 10 years alone.
  • The company has received WHO prequalification of its Japanese encephalitis, DTwP and Td as well as measles and rubella vaccines and also commenced commercial operations in the US.
image_pdfMake PDF
Source: Indian Express
Tags: PrelimsThe Indian Express

Related Posts

Breast tissue density’s role in detecting breast cancer

Breast tissue density’s role in detecting breast cancer

May 1, 2023
LUPEX mission

LUPEX mission

April 29, 2023
What is the Big Catch-up initiative?

What is the Big Catch-up initiative?

April 28, 2023
Shingrix vaccine

Shingrix vaccine

April 28, 2023
India’s first digital park

India’s first digital park

April 25, 2023
TeLEOS-2 and Lumelite-4

TeLEOS-2 and Lumelite-4

April 24, 2023
The State of the World’s Children 2023

The State of the World’s Children 2023

April 24, 2023
National Quantum Mission

National Quantum Mission

April 21, 2023
First test flight of SpaceX’s big Starship

First test flight of SpaceX’s big Starship

April 17, 2023
Bengaluru to get India’s 1st 3D printed post office

Bengaluru to get India’s 1st 3D printed post office

April 14, 2023
Please login to join discussion
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tag

AIR All India Radio BBC Business Line Business Standard dow Down to Earth DownToEarth DTE Economic Times ET FAO Financial Express GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express Indiatoday India today Kurukshetra Livelihoods portal LiveMint Mains News Newspaper News Paper PIB Prelims PRS India RSTV Science Reporter Survey The Hindu The India Express The Indian Express The Print the wire Times of India TOI TOPPERS Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In